ID

24846

Descripción

Study ID: 100571 (M138) Clinical Study ID: 100571 Study Title: Double-blind randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 12 month schedule in healthy adult volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A https://clinicaltrials.gov/ct2/show/NCT00291876

Link

https://clinicaltrials.gov/ct2/show/NCT00291876

Palabras clave

Versiones (1)
  1. 19/8/17 19/8/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

19 de agosto de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

GSK Hepatitis A Vaccine Tracking Document Long Term Follow-up NCT00291876

Inglés

GSK Hepatitis A Vaccine Tracking Document Long Term Follow-up NCT00291876

1 formularios  
Study administration
Descripción

Study administration

Center
Descripción

Center

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Long Term Follow-up
Descripción

Long Term Follow-up

Subject number of previous study
Descripción

Subject number of previous study

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2348585
UMLS CUI [1,2]
C2242969
Subject initials first name family name
Descripción

Subject initials

Tipo de datos

text

Alias
UMLS CUI [1]
C2986440
Date of birth
Descripción

Date of birth

Tipo de datos

date

Unidades de medida
  • day month year
Alias
UMLS CUI [1]
C0421451
day month year
Please contact the following subjects for inclusion in the long-term follow-up study and document whether or not he/she agrees to participate.
Descripción

study subject participation subject

Tipo de datos

integer

Alias
UMLS CUI [1]
C2348568
If answer is 3., choose
Descripción

study subject participation status adverse event

Tipo de datos

integer

Alias
UMLS CUI [1]
C2348568
please specify
Descripción

study subject participation status specify

Tipo de datos

text

Alias
UMLS CUI [1]
C2348568
Date of contact
Descripción

Date of contact

Tipo de datos

date

Alias
UMLS CUI [1]
C0805839
Investigator
Descripción

Investigator

Investigator name
Descripción

Investigator name

Tipo de datos

text

Alias
UMLS CUI [1]
C2826892
Signature
Descripción

Signature

Tipo de datos

text

Alias
UMLS CUI [1]
C1519316
Date
Descripción

Signature date

Tipo de datos

date

Alias
UMLS CUI [1]
C0807937
Volver a la parte superior de la página

Similar models

GSK Hepatitis A Vaccine Tracking Document Long Term Follow-up NCT00291876

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Study administration
Center
Item
Center
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Item Group
Long Term Follow-up
Subject number of previous study
Item
Subject number of previous study
text
C2348585 (UMLS CUI [1,1])
C2242969 (UMLS CUI [1,2])
Subject initials
Item
Subject initials first name family name
text
C2986440 (UMLS CUI [1])
Date of birth
Item
Date of birth
date
C0421451 (UMLS CUI [1])
Item
Please contact the following subjects for inclusion in the long-term follow-up study and document whether or not he/she agrees to participate.
integer
C2348568 (UMLS CUI [1])
study subject participation subject
Code List
Please contact the following subjects for inclusion in the long-term follow-up study and document whether or not he/she agrees to participate.
CL Item
1. Subject not eligible (1)
CL Item
2. Subject lost to follow-up or not reached (2)
CL Item
3. Subject eligible but not willing to participate due to: (3)
CL Item
4. Subject eligible and agreed to participate in the (4)
CL Item
long-term follow-up study (5)
Item
If answer is 3., choose
integer
C2348568 (UMLS CUI [1])
study subject participation subject
Code List
If answer is 3., choose
CL Item
adverse events, or serious adverse event: (1)
CL Item
other: (2)
study subject participation status specify
Item
please specify
text
C2348568 (UMLS CUI [1])
Date of contact
Item
Date of contact
date
C0805839 (UMLS CUI [1])
Item Group
Investigator
Investigator name
Item
Investigator name
text
C2826892 (UMLS CUI [1])
Signature
Item
Signature
text
C1519316 (UMLS CUI [1])
Signature date
Item
Date
date
C0807937 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial